Physician profile
Tiffany Noel Morgan
NPI 1780985184
$590,371.79
in general payments reported to CMS, 2019-2025
8 companies · $390K in 2025
The $390K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.71 · 2022: $45.61 · 2023: $28K · 2024: $172K · 2025: $390K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $532K · Travel and Lodging: $49K · Food and Beverage: $8,765 · Education: $54.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $532,455.00 |
| Travel and Lodging | $48,983.98 |
| Food and Beverage | $8,765.19 |
| Education | $54.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $589,688.74 | 2023-2025 | |
| Boston Scientific Corporation | $388.44 | 2023-2025 | Watchman Flx, Comet, Eluvia |
| Galderma Laboratories, L.P. | $142.24 | 2021-2025 | Dysport |
| Allergan, INC. | $45.61 | 2022 | |
| Ethicon US, LLC | $43.91 | 2025 | Vistaseal |
| Becton, Dickinson and Company | $30.13 | 2024 | |
| Davol INC. | $22.02 | 2024 | |
| Abbott Laboratories | $10.70 | 2024 | Jeti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.